Bioventix PLC (LON:BVXP – Get Free Report)’s share price hit a new 52-week low during trading on Monday . The stock traded as low as GBX 2,400 ($31.03) and last traded at GBX 2,420 ($31.29), with a volume of 26011 shares. The stock had previously closed at GBX 2,750 ($35.56).
Bioventix Trading Down 12.0 %
The company has a fifty day moving average price of GBX 2,908.58 and a two-hundred day moving average price of GBX 3,367.22. The firm has a market cap of £126.72 million, a P/E ratio of 15.65 and a beta of 0.35.
Bioventix (LON:BVXP – Get Free Report) last released its quarterly earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.93) earnings per share for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. As a group, sell-side analysts expect that Bioventix PLC will post 166.3066955 EPS for the current year.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Stories
- Five stocks we like better than Bioventix
- Breakout Stocks: What They Are and How to Identify Them
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- What is Put Option Volume?
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Why Invest in High-Yield Dividend Stocks?
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
